JPS62135479A - アルキルカルバモイルオキシセフエム化合物 - Google Patents

アルキルカルバモイルオキシセフエム化合物

Info

Publication number
JPS62135479A
JPS62135479A JP61184397A JP18439786A JPS62135479A JP S62135479 A JPS62135479 A JP S62135479A JP 61184397 A JP61184397 A JP 61184397A JP 18439786 A JP18439786 A JP 18439786A JP S62135479 A JPS62135479 A JP S62135479A
Authority
JP
Japan
Prior art keywords
acid
equivalents
parts
ester
carboxylic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP61184397A
Other languages
English (en)
Japanese (ja)
Inventor
Yoshio Hamashima
浜島　好男
Shoji Tsuji
辻　照二
Tetsuo Okada
哲夫 岡田
Kyoji Minami
南　恭二
Hiroyuki Ishitobi
石飛　寛幸
Koji Ishikura
公二 石倉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Publication of JPS62135479A publication Critical patent/JPS62135479A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
JP61184397A 1985-08-05 1986-08-05 アルキルカルバモイルオキシセフエム化合物 Pending JPS62135479A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP17266085 1985-08-05
JP60-172660 1985-08-05

Publications (1)

Publication Number Publication Date
JPS62135479A true JPS62135479A (ja) 1987-06-18

Family

ID=15946013

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61184397A Pending JPS62135479A (ja) 1985-08-05 1986-08-05 アルキルカルバモイルオキシセフエム化合物

Country Status (8)

Country Link
US (1) US4731362A (2)
JP (1) JPS62135479A (2)
KR (1) KR930004015B1 (2)
CH (1) CH669384A5 (2)
DE (1) DE3626509A1 (2)
FR (1) FR2585704B1 (2)
GB (1) GB2178740B (2)
IT (1) IT1195816B (2)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6393796A (ja) * 1986-10-09 1988-04-25 Shin Etsu Chem Co Ltd ペプチド合成の脱保護基用薬剤
IL94946A0 (en) * 1989-07-13 1991-06-10 Eisai Co Ltd 3-substituted vinyl cephalosporin derivatives,their preparation and pharmaceutical compositions containing them
TW203552B (en) * 1992-02-18 1993-04-11 J Baroody Lloyd Compositions of clindamycin and benzoyl peroxide for acne treatment
US6063363A (en) * 1997-05-27 2000-05-16 Goodwin; Gary J Treatment for upper respiratory tract infections with potassium salts
JP3531648B2 (ja) 1998-08-04 2004-05-31 武田シェリング・プラウ アニマルヘルス株式会社 β−ラクタム抗生物質の安定化製剤
US20040167223A1 (en) * 2002-09-03 2004-08-26 Popp Karl F. Topical antibacterial formulations
US20040171561A1 (en) * 2002-09-03 2004-09-02 Popp Karl F. Topical formulations for treatment of rosacea
US20040043946A1 (en) * 2002-09-03 2004-03-04 Popp Karl F. Topical formulations for treatment of skin disorders
ES2560540T3 (es) 2006-03-31 2016-02-19 Stiefel Research Australia Pty Ltd Gel en suspensión espumable
CN101747344B (zh) * 2009-12-22 2012-07-04 山东润泽制药有限公司 盐酸头孢卡品酯的合成方法
CN104829632B (zh) * 2015-05-20 2017-09-29 中山大学 一种含二硫代氨基甲酸取代基的头孢菌素衍生物
CN120404996B (zh) * 2025-07-07 2025-09-23 湖北科林博伦新材料有限公司 一种甲苯氧化法生产苯甲醇工艺碱水中乙酸钠含量的分析方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1415813A (fr) * 1963-10-07 1965-10-29 Ciba Geigy Dérivés de l'acide 7-amino-céphalosporanique et procédé pour leur préparation
US4368198A (en) * 1976-03-03 1983-01-11 Sumitomo Chemical Company Limited Cephalosporins
DE3037997A1 (de) * 1980-10-08 1982-05-13 Bayer Ag (beta) -lactamantibiotika, verfahren zu deren herstellung sowie sie enthaltende mittel
IE53429B1 (en) * 1981-08-03 1988-11-09 Fujisawa Pharmaceutical Co New cephem compounds and processes for preparation thereof
DE3145727A1 (de) * 1981-11-19 1983-05-26 Bayer Ag, 5090 Leverkusen Zwischenprodukte, verfahren zu deren herstellung und verfahren zur herstellung von cephalosporinen
AU575854B2 (en) * 1983-10-04 1988-08-11 Shionogi & Co., Ltd. 7beta-(carboxyalkenamido) cephalosporins

Also Published As

Publication number Publication date
FR2585704B1 (fr) 1991-11-29
GB8619038D0 (en) 1986-09-17
GB2178740A (en) 1987-02-18
IT8667632A0 (it) 1986-08-05
KR930004015B1 (ko) 1993-05-19
DE3626509A1 (de) 1987-02-12
FR2585704A1 (fr) 1987-02-06
KR870002150A (ko) 1987-03-30
CH669384A5 (2) 1989-03-15
IT1195816B (it) 1988-10-27
US4731362A (en) 1988-03-15
GB2178740B (en) 1989-08-23
IT8667632A1 (it) 1988-02-05

Similar Documents

Publication Publication Date Title
JP2969283B2 (ja) ピペラジニオセファロスポリン
US4912224A (en) Carboxyalkenamidocephalosporins
JPS62135479A (ja) アルキルカルバモイルオキシセフエム化合物
US4254119A (en) 3-Unsubstituted-3-cephem compounds
JP2971534B2 (ja) フェナシル化ピリジニオチオセファロスポリン
GB2173194A (en) 7-beta-(2-(amino-4-thiazolyl)-2-alkenoylamino)-3-cephem-4-carboxylic acid ester derivativess
JPH08245633A (ja) セファロスポリン誘導体
JPS59231090A (ja) フルオロメチルチオオキサセフアロスポリン
JP3238209B2 (ja) チオメチルチオカルバセファロスポリン誘導体
JPS6016989A (ja) オキソ飽和異項環カルボンアミドセフエム化合物
JP2567799B2 (ja) カルボキシアルケン酸及びその誘導体
JP2973126B2 (ja) 新規なペナム誘導体およびその塩
JP2566680B2 (ja) ビニルチオ酢酸誘導体
US4182868A (en) 7-Methoxycephalosporin derivatives
JPH0859669A (ja) セフェム化合物、その製造法及び剤
JPS60163884A (ja) カルボキシアルケンアミドセフアロスポリン
JPS61130293A (ja) ふつ素化アルキルセフアロスポリン類
JPH0454673B2 (2)
JPS60197689A (ja) オキサセフアロスポリンのビニルチオ誘導体
IE46627B1 (en) Haloarylmalonamidooxacephalosporins
JPS63132892A (ja) ピリジニウムチオメチルセフアロスポリン
JPS60123490A (ja) マロニルオキサセフェムカルボン酸誘導体
JPS63183589A (ja) 新規セフェム化合物
JPS60130590A (ja) 置換メチルチオメチルセフアロスポリン類